国际皮肤性病学杂志    0  (): 329-331   ISSN: 2096-5540  CN: 32-1880/R   光疗及光化学疗法治疗结缔组织病进展 田夫军, 张福仁 山东省皮肤病性病防治研究所 济南 250022 收稿日期 2005-03-14  修回日期 null  网络版发布日期 null 参考文献  [1] Sato S, Kodera M, Hasegawa M,et al. Antinucleosome antibody is a major autoantibody in localized scleroderma. Br J Dermatol, 2004, 151:1182-1188. [2] El-Mofty M, Mostafa W, Esmat S, et al. Suggested mechanisms of action of UVA phototherapy in morphea:a molecular study. Photodermatol Photoimmunol Photomed, 2004, 20:93-100. [3] El-Mofty M, Mostafa W, El-Darouty M, et al. Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis. Photodermatol Photoimmunol Photomed, 2004, 20:148-156. [4] de Rie MA, Enomoto DN, de Vries HJ, et al. Evaluation of mediumdose UVA1 phototherapy in localized scleroderma with the cutometer and fast Fourier transform method. Dermatology, 2003, 207:298. [5] Grundmann-Kollmann M, Ochsendorf F, Zollner TM, et al. PUVA cream photochemotherapy for the treatment of localized scleroderma. J Am Acad Dermatol, 2000, 43:675-678. [6] Yin L, Yamauchi R, Tsuji T, et al. The expression of matrix metalloproteinase-1 mRNA induced by ultraviolet A1 (340-400 nm) isphototherapy relevant to the glutathione (GSH) content in skin fi broblasts of systemic sclerosis. J Dermatol, 2003, 30:173-180. [7] Kreuter A, Breuckmann F, Uhle A, et al. Low-dose UVA1 phototherapy in systemic sclerosis:effects on acrosclerosis. J Am Acad Dermatol, 2004, 50:740-747. [8] Morita A, Kobayashi K, Isomura I, et al. Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis. J Am Acad Dermatol, 2000, 43:670-674. [9] Breuckmann F, Stuecker M, Altmeyer P, et al. Modulation of en dothelial dysfunction and apoptosis:UVA1-mediated skin improvement in systemic sclerosis. Arch Dermatol Res, 2004, 296:235. [10] Breuckmann F, Appelhans C, Bastian A, et al. UVA1-induced decrease in dermal neuron-specific enolase (NSE) in acrosclerosis. Arch Dermatol Res, 2004, 296:182-184. [11] Hofer A, Soyer HP. Oral psoralen-UV-A for systemic scleroderma. Arch Dermatol, 1999, 135:603-604. [12] Kreuter A, Jansen T, Stucker M, et al. Low-dose ultraviolet-A1 phototherapy for lichen sclerosus et atrophicus. Clin Exp Dermatol, 2001, 26:30-32. [13] Kreuter A, Gambichler T, Avermaete A, et al. Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus:results of a preliminary study. J Am Acad Dermatol, 2002, 46:251-255. [14] Reichrath J, Reinhold U, Tilgen W. Treatment of genito-anal lesions in inflammatory skin diseases with PUVA cream photochemotherapy:an open pilot study in 12 patients. Dermatology, 2002, 205:245-248. [15] Polderman MC, Huizinga TW, Le Cessie S, et al. UVA-1 cold light treatment of SLE:a double blind, placebo controlled crossover trial. Ann Rheum Dis, 2001, 60:112-115. [16] Polderman MC, le Cessie S, Huizinga TW, et al. Efficacy of UVA-1 cold light as an adjuvant therapy for systemic lupus erythematosus. Rheumatology (Oxford), 2004, 43:1402-1404. [17] Breuckmann F, Avermaete A, Kreuter A, et al. Indications for UVA1 phototherapy:An Update. Photodermatol Photoimmunol Photomed, 2001, 17:83. [18] Schiener R, Behrens-Williams SC, Gottlober P, et al. Eosinophilic fasciitis treated with psoralen-ultraviolet A bath photochemotherapy.Br J Dermatol, 2000, 142:804-807. [19] Yildirim M, Baysal V, Aridogan BC, et al. Pansclerotic morphea treated with UVA:a case report. J Dermatol, 2003, 30:625-627. [20] Scharffetter-Kochanek K, Goldermann R, Lehmann P, et al. PUVA therapy in disabling pansclerotic morphoea of children. Br J Dermatol, 1995, 132:830-831. [21] Adachi Y, Iba S, Horio T. Successful treatment of lichen myxoedematosus with PUVA photochemotherapy. hotodermatol Photoimmunol Photomed, 2000, 6:229-231. [22] rundmann-Kollmann M, Ochsendorf F, Zollner TM, et al. Cream PUVA therapy for scleredema adultorum. Br J Dermatol, 2000, 142:1058. [23] Schaller M, Romiti R, Wollenberg A, et al. Improvement of cutaneous manifestations in POEMS syndrome after UVA1 phototherapy. J Am Acad Dermatol, 2001, 45:969-970. 通讯作者: